Cargando…

Complications related to elective generator replacement of the subcutaneous implantable defibrillator

AIMS: To guarantee uninterrupted function of the subcutaneous implantable cardioverter-defibrillator (S-ICD), the pulse generator needs to be surgically replaced before the battery is depleted. The risks related to this replacement substantially impact long-term outcome for S-ICD recipients, as the...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Stuijt, Willeke, Quast, Anne-Floor B E, Baalman, Sarah W E, de Wilde, Koen C, Brouwer, Tom F, Wilde, Arthur A M, Knops, Reinoud E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947576/ https://www.ncbi.nlm.nih.gov/pubmed/33197266 http://dx.doi.org/10.1093/europace/euaa263

Ejemplares similares

Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement
por: de Veld, Jolien A, et al.
Publicado: (2023)

Long‐term follow‐up of the two‐incision implantation technique for the subcutaneous implantable cardioverter‐defibrillator
por: van der Stuijt, Willeke, et al.
Publicado: (2020)

High shock impedance during subcutaneous implantable defibrillator generator replacements: Authors’ reply
por: van der Stuijt, Willeke, et al.
Publicado: (2021)

Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?
por: van der Stuijt, W., et al.
Publicado: (2020)

Comparison of complications and shocks in paediatric and young transvenous and subcutaneous implantable cardioverter-defibrillator patients
por: Quast, A. B. E., et al.
Publicado: (2018)

Noise caused by involuntary muscle response may inhibit detection of ventricular fibrillation during defibrillation testing
por: Baalman, Sarah W.E., et al.
Publicado: (2019)

An Overview of Clinical Outcomes in Transvenous and Subcutaneous ICD Patients
por: Baalman, S. W. E., et al.
Publicado: (2018)

The learning curve associated with the introduction of the subcutaneous implantable defibrillator
por: Knops, Reinoud E., et al.
Publicado: (2016)

Reduction in long-term mortality using remote device monitoring in a large real-world population of patients with implantable defibrillators
por: Kolk, Maarten Z H, et al.
Publicado: (2023)

Accuracy and clinical relevance of the single-lead Apple Watch electrocardiogram to identify atrial fibrillation
por: Pepplinkhuizen, Shari, et al.
Publicado: (2022)

Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study
por: Lambiase, Pier D, et al.
Publicado: (2022)

Optimizing patient selection for primary prevention implantable cardioverter-defibrillator implantation: utilizing multimodal machine learning to assess risk of implantable cardioverter-defibrillator non-benefit
por: Kolk, Maarten Z H, et al.
Publicado: (2023)

Successful replacement of the longest worldwide in situ Nanostim leadless cardiac pacemaker for a Micra Transcatheter Pacing System
por: Beurskens, Niek E. G., et al.
Publicado: (2018)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021)

Outpatient treatment with the wearable cardioverter defibrillator: clinical experience in two Dutch centres
por: Quast, A. F. B. E., et al.
Publicado: (2017)

Do we understand the rationale behind driving restrictions in patients with an implantable cardioverter defibrillator?
por: Baalman, S. W. E., et al.
Publicado: (2018)

Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long‐Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter‐Defibrillator (the eCTOpy‐in‐ICD Study)
por: van Dongen, Ivo M., et al.
Publicado: (2018)

Shoulder Joint Dislocation as an Unusual Complication of Defibrillation Threshold Testing Following Subcutaneous Implantable Cardioverter-Defibrillator Implantation
por: Noheria, Amit, et al.
Publicado: (2014)

Real‐world performance of the atrial fibrillation monitor in patients with a subcutaneous ICD
por: Baalman, Sarah W.E., et al.
Publicado: (2020)

Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes
por: Lambiase, Pier D., et al.
Publicado: (2020)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Subcutaneous defibrillator implantation in pediatric patients
por: Ertuğrul, İlker, et al.
Publicado: (2016)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

A cracking complication: Displacement of existing clavicle fracture complicating subcutaneous implantable cardioverter defibrillator implantation
por: Ismail, Umar, et al.
Publicado: (2020)

First experience with the wearable cardioverter defibrillator in the Netherlands
por: Knops, R. E., et al.
Publicado: (2011)

Approaches to Minimizing Periprocedural Complications During Subcutaneous Implantable Cardioverter-defibrillator Placement
por: Vedachalam, Srikanth, et al.
Publicado: (2020)

Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020)

Implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with epicardial defibrillation patches
por: Yoshizawa, Reisuke, et al.
Publicado: (2021)

Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial
por: Knops, Reinoud E, et al.
Publicado: (2022)

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
por: Souza, Fernando Sérgio Oliva, et al.
Publicado: (2017)

Subcutaneous implantable defibrillator in dextrocardia secondary to Lobectomy
por: Monkhouse, Christopher, et al.
Publicado: (2018)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry
por: Lambiase, Pier D., et al.
Publicado: (2014)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
por: Kawamura, Iwanari, et al.
Publicado: (2019)

Subcutaneous Implantable Cardioverter Defibrillators Implantation Without Defibrillation Threshold Testing: A Single Center Experience
por: Al-Ghamdi, Bandar, et al.
Publicado: (2017)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

The subcutaneous implantable cardioverter defibrillator––review of the recent data
por: Westerman, Stacy B, et al.
Publicado: (2018)

An “UninTENSional” Subcutaneous Implantable Cardioverter-defibrillator Shock
por: Turner, Suzette L., et al.
Publicado: (2018)

Inappropriate subcutaneous implantable cardioverter-defibrillator shocks for bradycardia
por: Chua, Kelvin C.M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_njbc81nidqnvam3v0hin0tu4o8